Diagnostics Pipeline
Building diagnostics across disease areas
myOLARIS® -KTdx is the first clinical proof of what the Olaris platform can do. The myOLARIS® diagnostic pipeline includes additional products in development across transplant medicine and other disease areas, including tools designed to support medication monitoring. Each product is built from the same platform and held to the same scientific standard.
Olaris builds and powers diagnostics at the intersection of metabolomics, machine learning, and biology, revealing what is happening in disease, not merely what could happen.
IN DEVELOPMENT
myOLARIS® -CVD LTdx
Plasma based assay to identify liver transplant recipients at increased risk for cardiovascular disease complications.
IN DEVELOPMENT
myOLARIS® -pKTdx
Non-invasive urine assay for surveillance of kidney graft injury in pediatric kidney transplant recipients.
AVAILABLE AS LDT
myOLARIS® -MMF Drug Signature
Non-invasive urine assay to detect MMF drug metabolites for medication monitoring.
AVAILABLE AS LDT
myOLARIS® -KTdx:
Non-invasive urine assay for surveillance of kidney graft injury in adult kidney transplant recipients.
Ready to see how myOLARIS® -KTdx fits your workflow?
Contact us for practical implementation materials and a walkthrough of the report format.